SEC Form 4 · accession 0001645627-17-000076
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Jun 5, 2017
Accepted (ET)
Jun 12, 2017 · 3:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 5, 2017 | P | 1,000 | $0.0599 | A | 21,096,349 | D | |
| Common Stock | Jun 5, 2017 | P | 1,000 | $0.0599 | A | 21,097,349 | D | |
| Common Stock | Jun 5, 2017 | P | 1,000 | $0.0599 | A | 21,098,349 | D | |
| Common Stock | Jun 5, 2017 | P | 1,000 | $0.0599 | A | 21,099,349 | D | |
| Common Stock | Jun 5, 2017 | P | 1,000 | $0.0595 | A | 21,100,349 | D | |
| Common Stock | Jun 5, 2017 | P | 1,000 | $0.0598 | A | 21,101,349 | D | |
| Common Stock | Jun 5, 2017 | P | 1,000 | $0.0598 | A | 21,102,349 | D | |
| Common Stock | Jun 5, 2017 | P | 1,000 | $0.0598 | A | 21,103,349 | D | |
| Common Stock | Jun 5, 2017 | P | 1,000 | $0.0574 | A | 21,104,349 | D | |
| Common Stock | Jun 5, 2017 | P | 1,000 | $0.0598 | A | 21,105,349 | D | |
| Common Stock | Jun 6, 2017 | P | 1,000 | $0.0599 | A | 21,106,349 | D | |
| Common Stock | Jun 6, 2017 | P | 1,000 | $0.0559 | A | 21,107,349 | D | |
| Common Stock | Jun 6, 2017 | P | 1,000 | $0.0599 | A | 21,108,349 | D | |
| Common Stock | Jun 6, 2017 | P | 1,000 | $0.0599 | A | 21,109,349 | D | |
| Common Stock | Jun 6, 2017 | P | 1,000 | $0.0599 | A | 21,110,349 | D |
Table II — derivative securities
No Table II lines on this filing.